Similarly to the intestinal transcriptome analysis, intra-tumoral IFN-γ expression was significantly enhanced in mice treated with B. bre JCM92 (boosting) and cancer therapeutics compared to mice treated with B. bre Bb03 (non-boosting) and cancer therapeutics. This evidence concerns the gene IFNG and cancer.